Microfluidics Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Microfluidics Market |
Microfluidics systems are a desirable option for assays
including biological and chemical assays because of advantages like less sample
and reagent usage, shorter analysis times, and simpler automation processes.
Additionally, microfluidics devices enable parallel assay execution, which
lowers the overall cost of the experiment. These technologies offer enormous
potential in the realm of point-of-care diagnostics based on next-generation
sequencing. Due to the manufacturing process' low cost, high level of system
integration, and portability, the Microfluidics
Market is expected to increase favourably
throughout the foreseeable future.
The demand for devices based on microfluidics technology is
rising as drug delivery applications advance. The development of numerous drug
delivery systems based on microfluidics, such as micro-needle arrays, inhaler
nozzles, transdermal, and micro-pumps, has a significant impact on drug
delivery because of its exact and predictable drug release.
The Microfluidics Market is dominated by North America, which
is largely due to the region's developed healthcare system and higher uptake of
innovative medicines by the general populace.
The field of microfluidics is rapidly expanding in the area
and has a large R&D budget. For instance, since 2000, PhRMA member
businesses have invested more than USD 1.1 Trillion in the hunt for novel
medicines and cures, including USD 102.3 Billion in 2021 alone, according to
the Pharmaceutical Research and Manufacturers of America data updates from
September 2021.
Additionally, over the course of the prediction, these are
anticipated to rise even further with growth in Microfluidics Market. One of the main destinations for
all the most current developments is the United States. In order to create
integrated microfluidic devices that are quick and simple to use, point-of-care
diagnostics leverages microfluidic technology for a variety of applications,
including molecular diagnostics, infectious diseases, and chronic diseases.
Researchers from the University of Illinois at
Urbana-Champaign presented a prototype of a quick COVID-19 molecular test in
August 2020. They also showed a portable device for reading the results on a
smartphone without sending samples to a lab.
Comments
Post a Comment